Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Kadmon Pharms Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for KADMON PHARMS LLC, and what generic and branded alternatives to KADMON PHARMS LLC drugs are available?

KADMON PHARMS LLC has four approved drugs.

Summary for Kadmon Pharms Llc
US Patents:0

Drugs and US Patents for Kadmon Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kadmon Pharms Llc RIBAVIRIN ribavirin TABLET;ORAL 077456-002 Dec 5, 2005 AB RX No No   Start Trial   Start Trial
Kadmon Pharms Llc TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 209415-001 Sep 16, 2019 AB RX No No   Start Trial   Start Trial
Kadmon Pharms Llc RIBAVIRIN ribavirin TABLET;ORAL 077456-003 Dec 5, 2005 AB RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.